Prof. Paul Abrams and Prof. Christopher Chapple provide an overview Overactive Bladder (OAB), covering a range of topics, including the pathophysiology of OAB, aetiology of OAB, how it is diagnosed, general overview to management, epidemiology and how OAB has become a more urgent focus.

Disclaimer:

* This presentation include products/indications which may not be approved in your country. Physicians should take into account the patient’s individual circumstances and consult the approved product information before prescribing.
* Astellas’ products availability, starting dose and indications may vary from country to country. These presentations are prepared solely for education of the healthcare professionals and does not necessarily reflect the opinions or recommendations of the sponsor.
* Astellas prohibits the promotion of unapproved drug usage and complies with all applicable laws, regulations, and company policies.

Approval code: INT-M-BET-202106-07

Episode 1: An Overview to Overactive Bladder (ft. Prof. Chris Chapple, UK)

The UK ranked among the worst hit countries for Covid-19 in Europe, and the severity of the pandemic required recurrent lockdown measures to be put in place. Prof. Chris Chapple (UK) describes what was a dramatic shift in access to care for OAB patients, including disruption of surgical procedures and limited access to diagnostic services. This episode will look at the impact of the pandemic on OAB care, focusing outpatient services management, patients’ quality of life and other potentially serious health risks. Despite the pandemic, use of telemedicine increased, and this is seen as a promising tool to help manage the long backlog of OAB management.

Disclaimer:

* This presentation include products/indications which may not be approved in your country. Physicians should take into account the patient’s individual circumstances and consult the approved product information before prescribing.
* Astellas’ products availability, starting dose and indications may vary from country to country. These presentations are prepared solely for education of the healthcare professionals and does not necessarily reflect the opinions or recommendations of the sponsor.
*Astellas prohibits the promotion of unapproved drug usage and complies with all applicable laws, regulations, and company policies.

Approval code: INT-M-BET-202106-06

Episode 2: OAB During the COVID-19 Pandemic (ft. Prof. Chris Chapple, UK)

Spontaneous voiding is a serious concern for OAB patients, and this can happen for a number of reasons, including poor OAB management, treatment not working (e.g. pelvic floor training not having an impact), and disease progression. For this reason, many OAB patients are often anxious because voiding can happen when they least expect it and when they least want it. WIth this in mind, many patients have build up coping strategies that help them reduce anxiety, overcome self-esteem concerns and build mitigating strategies to become more confident.

Chris offers his personal perspective of spontaneous voiding and share a very human experience of how to cope with this issue.

Approval code: INT-M-BET-202106-11

Episode 1: Overcoming Anxiety Over Sudden Voiding ft. Chris Chatterton (UK)

In this bonus clip Chris discusses the struggle of opening up, brought on by the fear of judgment from others about his condition.

Approval code: INT-M-BET-202106-12

Astellas Pharma